AzathioprineUstekinumabUpadacitinibRisankizumabadalimumabVedolimumabinfliximabUlcerative colitisCrohn’s disease
…dalimumab,50% Vedolimumab,66%(n=4) had Ustekinumab,66%(n=4) had Azathioprine. All patients received UPA as monotherapy.UPA induction was adm…